Tredegar (TG) director buys 2,844 shares at $7.91

Christine R. Vlahcevic, a director of Tredegar Corporation (TG), reported a personal purchase of 2,844 shares of Tredegar common stock on 10/01/2025 at a price of $7.91 per share.

Rhea-AI Filing Summary

Christine R. Vlahcevic, a director of Tredegar Corporation (TG), reported a personal purchase of 2,844 shares of Tredegar common stock on 10/01/2025 at a price of $7.91 per share. After the transaction she beneficially owned 7,986 shares. The Form 4 was signed by an attorney-in-fact on 10/03/2025. The filing shows a straightforward open-market acquisition with no derivatives, amendments, or additional explanatory text provided.

Positive

• Director purchase of 2,844 shares indicates insider buying
• Transaction executed at $7.91 per share, fully reported on Form 4

Negative

• None.

Insights

Corporate Governance Analyst

Director purchased shares: 2,844 at $7.91 on 10/01/2025.

This Form 4 discloses an insider purchase by Christine R. Vlahcevic, a company director, increasing her beneficial holding to 7,986 shares. The transaction is reported as a direct acquisition of common stock and shows no derivative activity.

This is a routine disclosure that signals a director-level buy rather than a sale; it is factual and limited to the single noted transaction. Because the filing contains no additional context, its investor impact is modest and mainly relevant for monitoring insider behavior.

Insider Trade Summary

Grant/Award: 2,844 shares

Grant/Award 1 txn

Insider VLAHCEVIC CHRISTINE R

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Tredegar Common Stock	2,844	$7.91	$22K

Holdings After Transaction: Tredegar Common Stock — 7,986 shares (Direct)

FAQ

What did Tredegar (TG) director Christine Vlahcevic report on Form 4?

The director reported purchasing 2,844 shares of Tredegar common stock on 10/01/2025 at $7.91 per share, bringing her beneficial ownership to 7,986 shares.

When was the Form 4 for TG filed and signed?

The transaction date is 10/01/2025 and the Form 4 was signed by an attorney-in-fact on 10/03/2025.

Does the Form 4 show any derivative transactions for TG?

No. Table II for derivative securities contains no entries; only a direct common stock acquisition is reported.

Did the reporting person act as an officer or a 10% owner?

The filing checks the box indicating the reporting person is a Director; no officer title or 10% owner box is checked.

How many shares does the director own after the reported transaction?

The director beneficially owns 7,986 shares following the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/03/2025 - 04:23 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

VLAHCEVIC CHRISTINE R

(Last) (First) (Middle)

1100 BOULDERS PARKWAY

(Street)

RICHMOND VA 23225

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TREDEGAR CORP [ TG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Tredegar Common Stock	10/01/2025		A		2,844	A	$7.91	7,986	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Kevin C. Donnelly, attorney-in-fact	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.